Description

Buy MARGENZA For Sale In USA

What is Margenza?

Margenza is a human epidermal growth factor receptor (HER2) inhibitor that slows or stops cell growth.Margenza injection is used in combination with other cancer drugs to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic). Buy MARGENZA For Sale In USA

Margenza is for use in people who have received at least two prior chemotherapy treatments for HER2-positive breast cancer.

Warnings

Margenza may cause heart problems. Call your doctor at once if you have symptoms such as: fast or pounding heartbeats, cough, shortness of breath, swelling, or rapid weight gain.

Margenza can cause harm to the unborn baby if used while pregnant. Effective contraception must be used during treatment and for 4 months following the last dose. Buy MARGENZA For Sale In USA

Before taking this medicine

Margenza may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant. Keep using birth control for at least 4 months after your last dose.

You may need to have a negative pregnancy test before starting this treatment.

It may not be safe to breastfeed while using Margenza, and for at least 4 months after your last dose. Ask your doctor about any risk.

Tell your doctor if you have ever had heart problems.

How is Margenza given?

Margenza is given as an infusion into a vein. A healthcare provider will give you this injection.

Margenza injection is usually given once every 3 weeks. Follow your doctor’s dosing instructions very carefully.

Margenza injection must be given slowly, and the infusion can take 30 minutes to 2 hours to complete. This medicine is sometimes given right after you’ve received other chemotherapy medication. Buy MARGENZA For Sale In USA

Your heart function may need to be checked using an electrocardiograph (sometimes called an EKG) or ultrasound. Your cancer treatments may be delayed or permanently discontinued based on the results.

Dosing information

Usual Adult Dose for Breast Cancer:

15 mg/kg IV every 3 weeks

Comment:
-Infuse initial dose over 120 minutes and subsequent doses over 30 minutes.
-This drug may be administered immediately after the completion of chemotherapy.
-Continue treatment until disease progression or unacceptable toxicity.
-All therapeutic proteins, including this drug, have the potential to produce an immune response.

Use: In combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease